-
1
-
-
84896711553
-
Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution
-
Dewhurst S.M., McGranahan N., Burrell R.A., Rowan A.J., Gronroos E., Endesfelder D., et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov 2014, 4:175-185.
-
(2014)
Cancer Discov
, vol.4
, pp. 175-185
-
-
Dewhurst, S.M.1
McGranahan, N.2
Burrell, R.A.3
Rowan, A.J.4
Gronroos, E.5
Endesfelder, D.6
-
2
-
-
84895876130
-
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
-
Gerlinger M., Horswell S., Larkin J., Rowan A.J., Salm M.P., Varela I., et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat. Genet 2014, 46:225-233.
-
(2014)
Nat. Genet
, vol.46
, pp. 225-233
-
-
Gerlinger, M.1
Horswell, S.2
Larkin, J.3
Rowan, A.J.4
Salm, M.P.5
Varela, I.6
-
3
-
-
84875884456
-
Cellular heterogeneity and molecular evolution in cancer
-
Almendro V., Marusyk A., Polyak K. Cellular heterogeneity and molecular evolution in cancer. Annu. Rev. Pathol 2013, 8:277-302.
-
(2013)
Annu. Rev. Pathol
, vol.8
, pp. 277-302
-
-
Almendro, V.1
Marusyk, A.2
Polyak, K.3
-
4
-
-
84899129255
-
Tumor heterogeneity in the clinic: is it a real problem
-
Janku F. Tumor heterogeneity in the clinic: is it a real problem. Ther. Adv. Med. Oncol 2014, 6:43-51.
-
(2014)
Ther. Adv. Med. Oncol
, vol.6
, pp. 43-51
-
-
Janku, F.1
-
5
-
-
63049123066
-
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
-
Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
-
(2009)
Nat. Rev. Cancer
, vol.9
, pp. 265-273
-
-
Polyak, K.1
Weinberg, R.A.2
-
6
-
-
79955420293
-
Cancer theory faces doubts
-
Ledford H. Cancer theory faces doubts. Nature 2011, 472:273.
-
(2011)
Nature
, vol.472
, pp. 273
-
-
Ledford, H.1
-
7
-
-
84873094470
-
Insights into cancer metastasis from a clinicopathologic perspective: epithelial-Mesenchymal Transition is not a necessary step
-
Chui M.H. Insights into cancer metastasis from a clinicopathologic perspective: epithelial-Mesenchymal Transition is not a necessary step. Int. J. Cancer 2013, 132:1487-1495.
-
(2013)
Int. J. Cancer
, vol.132
, pp. 1487-1495
-
-
Chui, M.H.1
-
8
-
-
84873811988
-
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition
-
Yu M., Bardia A., Wittner B.S., Stott S.L., Smas M.E., Ting D.T., et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013, 339:580-584.
-
(2013)
Science
, vol.339
, pp. 580-584
-
-
Yu, M.1
Bardia, A.2
Wittner, B.S.3
Stott, S.L.4
Smas, M.E.5
Ting, D.T.6
-
9
-
-
84856088337
-
EMT and dissemination precede pancreatic tumor formation
-
Rhim A.D., Mirek E.T., Aiello N.M., Maitra A., Bailey J.M., McAllister F., et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012, 148:349-361.
-
(2012)
Cell
, vol.148
, pp. 349-361
-
-
Rhim, A.D.1
Mirek, E.T.2
Aiello, N.M.3
Maitra, A.4
Bailey, J.M.5
McAllister, F.6
-
10
-
-
84894267835
-
Intratumoral hepatic stellate cells as a poor prognostic marker and a new treatment target for hepatocellular carcinoma
-
Sun B., Zhang X., Cheng X., Zhang Y., Chen L., Shi L., et al. Intratumoral hepatic stellate cells as a poor prognostic marker and a new treatment target for hepatocellular carcinoma. PLoS ONE 2013, 8:e80212.
-
(2013)
PLoS ONE
, vol.8
, pp. e80212
-
-
Sun, B.1
Zhang, X.2
Cheng, X.3
Zhang, Y.4
Chen, L.5
Shi, L.6
-
11
-
-
34547734520
-
Isolated tumour cells in blood and E-cadherin expression in oesophageal squamous cell cancer
-
Setoyama T., Natsugoe S., Okumura H., Matsumoto M., Uchikado Y., Aikou T. Isolated tumour cells in blood and E-cadherin expression in oesophageal squamous cell cancer. Br. J. Surg 2007, 94:984-991.
-
(2007)
Br. J. Surg
, vol.94
, pp. 984-991
-
-
Setoyama, T.1
Natsugoe, S.2
Okumura, H.3
Matsumoto, M.4
Uchikado, Y.5
Aikou, T.6
-
12
-
-
80053578949
-
A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition
-
Kumar S., Park S.H., Cieply B., Schupp J., Killiam E., Zhang F., et al. A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition. Mol. Cell. Biol 2011, 31:4036-4051.
-
(2011)
Mol. Cell. Biol
, vol.31
, pp. 4036-4051
-
-
Kumar, S.1
Park, S.H.2
Cieply, B.3
Schupp, J.4
Killiam, E.5
Zhang, F.6
-
13
-
-
82755190844
-
Anoikis: an emerging hallmark in health and diseases
-
Taddei M.L., Giannoni E., Fiaschi T., Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J. Pathol 2012, 226:380-393.
-
(2012)
J. Pathol
, vol.226
, pp. 380-393
-
-
Taddei, M.L.1
Giannoni, E.2
Fiaschi, T.3
Chiarugi, P.4
-
14
-
-
44449111555
-
Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways
-
Onder T.T., Gupta P.B., Mani S.A., Yang J., Lander E.S., Weinberg R.A. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008, 68:3645-3654.
-
(2008)
Cancer Res
, vol.68
, pp. 3645-3654
-
-
Onder, T.T.1
Gupta, P.B.2
Mani, S.A.3
Yang, J.4
Lander, E.S.5
Weinberg, R.A.6
-
15
-
-
84870845421
-
Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis
-
Tsai J.H., Donaher J.L., Murphy D.A., Chau S., Yang J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012, 22:725-736.
-
(2012)
Cancer Cell
, vol.22
, pp. 725-736
-
-
Tsai, J.H.1
Donaher, J.L.2
Murphy, D.A.3
Chau, S.4
Yang, J.5
-
16
-
-
84870816403
-
Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1
-
Ocana O.H., Corcoles R., Fabra A., Moreno-Bueno G., Acloque H., Vega S., et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 2012, 22:709-724.
-
(2012)
Cancer Cell
, vol.22
, pp. 709-724
-
-
Ocana, O.H.1
Corcoles, R.2
Fabra, A.3
Moreno-Bueno, G.4
Acloque, H.5
Vega, S.6
-
17
-
-
84860608896
-
Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases
-
Chao Y., Wu Q., Acquafondata M., Dhir R., Wells A. Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron 2012, 5:19-28.
-
(2012)
Cancer Microenviron
, vol.5
, pp. 19-28
-
-
Chao, Y.1
Wu, Q.2
Acquafondata, M.3
Dhir, R.4
Wells, A.5
-
18
-
-
80052511419
-
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
-
Farace F., Massard C., Vimond N., Drusch F., Jacques N., Billiot F., et al. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br. J. Cancer 2011, 105:847-853.
-
(2011)
Br. J. Cancer
, vol.105
, pp. 847-853
-
-
Farace, F.1
Massard, C.2
Vimond, N.3
Drusch, F.4
Jacques, N.5
Billiot, F.6
-
19
-
-
37549002543
-
Isolation of rare circulating tumour cells in cancer patients by microchip technology
-
Nagrath S., Sequist L.V., Maheswaran S., Bell D.W., Irimia D., Ulkus L., et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450:1235-1239.
-
(2007)
Nature
, vol.450
, pp. 1235-1239
-
-
Nagrath, S.1
Sequist, L.V.2
Maheswaran, S.3
Bell, D.W.4
Irimia, D.5
Ulkus, L.6
-
20
-
-
79957815376
-
Future medical applications of single-cell sequencing in cancer
-
Navin N., Hicks J. Future medical applications of single-cell sequencing in cancer. Genome Med 2011, 3:31.
-
(2011)
Genome Med
, vol.3
, pp. 31
-
-
Navin, N.1
Hicks, J.2
-
21
-
-
57349126306
-
Cancer stem cells: here, there, everywhere
-
Eaves C.J. Cancer stem cells: here, there, everywhere. Nature 2008, 456:581-582.
-
(2008)
Nature
, vol.456
, pp. 581-582
-
-
Eaves, C.J.1
-
22
-
-
21744462604
-
Cancer biology: summing up cancer stem cells
-
Huntly B.J., Gilliland D.G. Cancer biology: summing up cancer stem cells. Nature 2005, 435:1169-1170.
-
(2005)
Nature
, vol.435
, pp. 1169-1170
-
-
Huntly, B.J.1
Gilliland, D.G.2
-
24
-
-
33845243362
-
Cancer as an evolutionary and ecological process
-
Merlo L.M., Pepper J.W., Reid B.J., Maley C.C. Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 2006, 6:924-935.
-
(2006)
Nat. Rev. Cancer
, vol.6
, pp. 924-935
-
-
Merlo, L.M.1
Pepper, J.W.2
Reid, B.J.3
Maley, C.C.4
-
25
-
-
0017167185
-
The clonal evolution of tumor cell populations
-
Nowell P.C. The clonal evolution of tumor cell populations. Science 1976, 194:23-28.
-
(1976)
Science
, vol.194
, pp. 23-28
-
-
Nowell, P.C.1
-
26
-
-
84928254065
-
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
-
283ra54
-
McGranahan N., Favero F., de Bruin E.C., Birkbak N.J., Szallasi Z., Swanton C. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci. Transl. Med 2015, 7:283ra54.
-
(2015)
Sci. Transl. Med
, vol.7
-
-
McGranahan, N.1
Favero, F.2
de Bruin, E.C.3
Birkbak, N.J.4
Szallasi, Z.5
Swanton, C.6
-
27
-
-
84880378159
-
Circulating tumour cells: insights into tumour heterogeneity
-
Hayes D.F., Paoletti C. Circulating tumour cells: insights into tumour heterogeneity. J. Intern. Med 2013, 274:137-143.
-
(2013)
J. Intern. Med
, vol.274
, pp. 137-143
-
-
Hayes, D.F.1
Paoletti, C.2
-
28
-
-
84927626602
-
Translational implications of tumor heterogeneity
-
Jamal-Hanjani M., Quezada S.A., Larkin J., Swanton C. Translational implications of tumor heterogeneity. Clin. Cancer Res 2015, 21:1258-1266.
-
(2015)
Clin. Cancer Res
, vol.21
, pp. 1258-1266
-
-
Jamal-Hanjani, M.1
Quezada, S.A.2
Larkin, J.3
Swanton, C.4
-
29
-
-
84875545819
-
Experts' opinion: recommendations for retesting breast cancer metastases for HER2 and hormone receptor status
-
Penault-Llorca F., Coudry R.A., Hanna W.M., Osamura R.Y., Ruschoff J., Viale G. Experts' opinion: recommendations for retesting breast cancer metastases for HER2 and hormone receptor status. Breast 2013, 22:200-202.
-
(2013)
Breast
, vol.22
, pp. 200-202
-
-
Penault-Llorca, F.1
Coudry, R.A.2
Hanna, W.M.3
Osamura, R.Y.4
Ruschoff, J.5
Viale, G.6
-
30
-
-
84873414664
-
Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer
-
Voutsina A., Tzardi M., Kalikaki A., Zafeiriou Z., Papadimitraki E., Papadakis M., et al. Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer. Mod. Pathol 2013, 26:302-313.
-
(2013)
Mod. Pathol
, vol.26
, pp. 302-313
-
-
Voutsina, A.1
Tzardi, M.2
Kalikaki, A.3
Zafeiriou, Z.4
Papadimitraki, E.5
Papadakis, M.6
-
31
-
-
80052707377
-
Heterogeneity of KRAS status may explain the subset of discordant KRAS status between primary and metastatic colorectal cancer
-
Watanabe T., Kobunai T., Yamamoto Y., Matsuda K., Ishihara S., Nozawa K., et al. Heterogeneity of KRAS status may explain the subset of discordant KRAS status between primary and metastatic colorectal cancer. Dis. Colon Rectum 2011, 54:1170-1178.
-
(2011)
Dis. Colon Rectum
, vol.54
, pp. 1170-1178
-
-
Watanabe, T.1
Kobunai, T.2
Yamamoto, Y.3
Matsuda, K.4
Ishihara, S.5
Nozawa, K.6
-
32
-
-
84856536814
-
Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment
-
Vermaat J.S., Nijman I.J., Koudijs M.J., Gerritse F.L., Scherer S.J., Mokry M., et al. Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment. Clin. Cancer Res 2012, 18:688-699.
-
(2012)
Clin. Cancer Res
, vol.18
, pp. 688-699
-
-
Vermaat, J.S.1
Nijman, I.J.2
Koudijs, M.J.3
Gerritse, F.L.4
Scherer, S.J.5
Mokry, M.6
-
33
-
-
84865186133
-
Comparative genomic analysis of primary versus metastatic colorectal carcinomas
-
Vakiani E., Janakiraman M., Shen R., Sinha R., Zeng Z., Shia J., et al. Comparative genomic analysis of primary versus metastatic colorectal carcinomas. J. Clin. Oncol 2012, 30:2956-2962.
-
(2012)
J. Clin. Oncol
, vol.30
, pp. 2956-2962
-
-
Vakiani, E.1
Janakiraman, M.2
Shen, R.3
Sinha, R.4
Zeng, Z.5
Shia, J.6
-
34
-
-
84928698324
-
KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma
-
Siyar E.A., Demirci U., Cakmak O.B., Ozturk A., Esbah O., Ozatli T., et al. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma. J. BUON 2015, 20:128-135.
-
(2015)
J. BUON
, vol.20
, pp. 128-135
-
-
Siyar, E.A.1
Demirci, U.2
Cakmak, O.B.3
Ozturk, A.4
Esbah, O.5
Ozatli, T.6
-
35
-
-
76049098292
-
Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases
-
Baldus S.E., Schaefer K.L., Engers R., Hartleb D., Stoecklein N.H., Gabbert H.E. Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clin. Cancer Res 2010, 16:790-799.
-
(2010)
Clin. Cancer Res
, vol.16
, pp. 790-799
-
-
Baldus, S.E.1
Schaefer, K.L.2
Engers, R.3
Hartleb, D.4
Stoecklein, N.H.5
Gabbert, H.E.6
-
36
-
-
84864042630
-
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma
-
Colombino M., Capone M., Lissia A., Cossu A., Rubino C., De Giorgi V., et al. BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma. J. Clin. Oncol 2012, 30:2522-2529.
-
(2012)
J. Clin. Oncol
, vol.30
, pp. 2522-2529
-
-
Colombino, M.1
Capone, M.2
Lissia, A.3
Cossu, A.4
Rubino, C.5
De Giorgi, V.6
-
37
-
-
84923013251
-
Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases
-
Mao C., Wu X.Y., Yang Z.Y., Threapleton D.E., Yuan J.Q., Yu Y.Y., et al. Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases. Sci. Rep 2015, 5:8065.
-
(2015)
Sci. Rep
, vol.5
, pp. 8065
-
-
Mao, C.1
Wu, X.Y.2
Yang, Z.Y.3
Threapleton, D.E.4
Yuan, J.Q.5
Yu, Y.Y.6
-
38
-
-
84863230091
-
Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor
-
Xu X., Hou Y., Yin X., Bao L., Tang A., Song L., et al. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 2012, 148:886-895.
-
(2012)
Cell
, vol.148
, pp. 886-895
-
-
Xu, X.1
Hou, Y.2
Yin, X.3
Bao, L.4
Tang, A.5
Song, L.6
-
39
-
-
84856452707
-
Analysis of the concordance in the EGFR pathway status between primary tumors and related metastases of colorectal cancer patients:implications for cancer therapy
-
Cejas P., Lopez-Gomez M., Aguayo C., Madero R., Moreno-Rubio J., de Castro Carpeno J., et al. Analysis of the concordance in the EGFR pathway status between primary tumors and related metastases of colorectal cancer patients:implications for cancer therapy. Curr. Cancer Drug Targets 2012, 12:124-131.
-
(2012)
Curr. Cancer Drug Targets
, vol.12
, pp. 124-131
-
-
Cejas, P.1
Lopez-Gomez, M.2
Aguayo, C.3
Madero, R.4
Moreno-Rubio, J.5
de Castro Carpeno, J.6
-
40
-
-
84864045330
-
EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas
-
Chen Z.Y., Zhong W.Z., Zhang X.C., Su J., Yang X.N., Chen Z.H., et al. EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas. Oncologist 2012, 17:978-985.
-
(2012)
Oncologist
, vol.17
, pp. 978-985
-
-
Chen, Z.Y.1
Zhong, W.Z.2
Zhang, X.C.3
Su, J.4
Yang, X.N.5
Chen, Z.H.6
-
41
-
-
84871135647
-
Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases
-
Kim H., Xu X., Yoo S.B., Sun P.L., Jin Y., Paik J.H., et al. Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases. Histopathology 2013, 62:305-314.
-
(2013)
Histopathology
, vol.62
, pp. 305-314
-
-
Kim, H.1
Xu, X.2
Yoo, S.B.3
Sun, P.L.4
Jin, Y.5
Paik, J.H.6
-
42
-
-
84863393080
-
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
-
Gerlinger M., Rowan A.J., Horswell S., Larkin J., Endesfelder D., Gronroos E., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med 2012, 366:883-892.
-
(2012)
N. Engl. J. Med
, vol.366
, pp. 883-892
-
-
Gerlinger, M.1
Rowan, A.J.2
Horswell, S.3
Larkin, J.4
Endesfelder, D.5
Gronroos, E.6
-
43
-
-
84898597696
-
Molecular and genetic diversity in the metastatic process of melanoma
-
Harbst K., Lauss M., Cirenajwis H., Winter C., Howlin J., Torngren T., et al. Molecular and genetic diversity in the metastatic process of melanoma. J. Pathol 2014, 233:39-50.
-
(2014)
J. Pathol
, vol.233
, pp. 39-50
-
-
Harbst, K.1
Lauss, M.2
Cirenajwis, H.3
Winter, C.4
Howlin, J.5
Torngren, T.6
-
44
-
-
84894583541
-
Emerging techniques in molecular detection of circulating tumor cells
-
Cho W.C. Emerging techniques in molecular detection of circulating tumor cells. Expert Rev. Mol. Diagn 2014, 14:131-134.
-
(2014)
Expert Rev. Mol. Diagn
, vol.14
, pp. 131-134
-
-
Cho, W.C.1
-
45
-
-
84883152670
-
Detecting circulating tumor cells: current challenges and new trends
-
Hong B., Zu Y. Detecting circulating tumor cells: current challenges and new trends. Theranostics 2013, 3:377-394.
-
(2013)
Theranostics
, vol.3
, pp. 377-394
-
-
Hong, B.1
Zu, Y.2
-
46
-
-
84889064612
-
Advances and critical concerns with the microfluidic enrichments of circulating tumor cells
-
Hyun K.A., Jung H.I. Advances and critical concerns with the microfluidic enrichments of circulating tumor cells. Lab Chip 2014, 14:45-56.
-
(2014)
Lab Chip
, vol.14
, pp. 45-56
-
-
Hyun, K.A.1
Jung, H.I.2
-
47
-
-
46949084705
-
Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor
-
Adams A.A., Okagbare P.I., Feng J., Hupert M.L., Patterson D., Gottert J., et al. Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. J. Am. Chem. Soc 2008, 130:8633-8641.
-
(2008)
J. Am. Chem. Soc
, vol.130
, pp. 8633-8641
-
-
Adams, A.A.1
Okagbare, P.I.2
Feng, J.3
Hupert, M.L.4
Patterson, D.5
Gottert, J.6
-
48
-
-
34547529462
-
Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells
-
Zheng S., Lin H., Liu J.Q., Balic M., Datar R., Cote R.J., et al. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J. Chromatogr. A 2007, 1162:154-161.
-
(2007)
J. Chromatogr. A
, vol.1162
, pp. 154-161
-
-
Zheng, S.1
Lin, H.2
Liu, J.Q.3
Balic, M.4
Datar, R.5
Cote, R.J.6
-
49
-
-
84908115631
-
Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells
-
Lin M., Chen J.F., Lu Y.T., Zhang Y., Song J., Hou S., et al. Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells. Acc. Chem. Res 2014, 47:2941-2950.
-
(2014)
Acc. Chem. Res
, vol.47
, pp. 2941-2950
-
-
Lin, M.1
Chen, J.F.2
Lu, Y.T.3
Zhang, Y.4
Song, J.5
Hou, S.6
-
50
-
-
84940720719
-
Aptamers selected to postoperative lung adenocarcinoma detect circulating tumor cells in human blood
-
Zamay G.S., Kolovskaya O.S., Zamay T.N., Glazyrin Y.E., Krat A.V., Zubkova O., et al. Aptamers selected to postoperative lung adenocarcinoma detect circulating tumor cells in human blood. Mol. Ther 2015, 23:1486-1496.
-
(2015)
Mol. Ther
, vol.23
, pp. 1486-1496
-
-
Zamay, G.S.1
Kolovskaya, O.S.2
Zamay, T.N.3
Glazyrin, Y.E.4
Krat, A.V.5
Zubkova, O.6
-
51
-
-
84942086661
-
A Combinatory strategy for detection of live CTCs using microfiltration and a new telomerase-selective adenovirus
-
Ma Y., Hao S., Wang S., Zhao Y., Lim B., Lei M., et al. A Combinatory strategy for detection of live CTCs using microfiltration and a new telomerase-selective adenovirus. Mol. Cancer Ther 2015, 14:835-843.
-
(2015)
Mol. Cancer Ther
, vol.14
, pp. 835-843
-
-
Ma, Y.1
Hao, S.2
Wang, S.3
Zhao, Y.4
Lim, B.5
Lei, M.6
-
52
-
-
79952755005
-
Circulating tumor cells as a window on metastasis biology in lung cancer
-
Hou J.M., Krebs M., Ward T., Sloane R., Priest L., Hughes A., et al. Circulating tumor cells as a window on metastasis biology in lung cancer. Am. J. Pathol 2011, 178:989-996.
-
(2011)
Am. J. Pathol
, vol.178
, pp. 989-996
-
-
Hou, J.M.1
Krebs, M.2
Ward, T.3
Sloane, R.4
Priest, L.5
Hughes, A.6
-
53
-
-
0034597794
-
Telomere states and cell fates
-
Blackburn E.H. Telomere states and cell fates. Nature 2000, 408:53-56.
-
(2000)
Nature
, vol.408
, pp. 53-56
-
-
Blackburn, E.H.1
-
54
-
-
70449977200
-
Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics
-
Vorhies J.S., Nemunaitis J.J. Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics. Biologics 2007, 1:367-376.
-
(2007)
Biologics
, vol.1
, pp. 367-376
-
-
Vorhies, J.S.1
Nemunaitis, J.J.2
-
55
-
-
61449210870
-
Enrichment of cancer cells using aptamers immobilized on a microfluidic channel
-
Phillips J.A., Xu Y., Xia Z., Fan Z.H., Tan W. Enrichment of cancer cells using aptamers immobilized on a microfluidic channel. Anal. Chem 2009, 81:1033-1039.
-
(2009)
Anal. Chem
, vol.81
, pp. 1033-1039
-
-
Phillips, J.A.1
Xu, Y.2
Xia, Z.3
Fan, Z.H.4
Tan, W.5
-
56
-
-
84864373438
-
Screening of aptamers on microfluidic systems for clinical applications
-
Weng C.H., Huang C.J., Lee G.B. Screening of aptamers on microfluidic systems for clinical applications. Sensors (Basel) 2012, 12:9514-9529.
-
(2012)
Sensors (Basel)
, vol.12
, pp. 9514-9529
-
-
Weng, C.H.1
Huang, C.J.2
Lee, G.B.3
-
57
-
-
18244406590
-
Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors
-
Solakoglu O., Maierhofer C., Lahr G., Breit E., Scheunemann P., Heumos I., et al. Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:2246-2251.
-
(2002)
Proc. Natl. Acad. Sci. U.S.A.
, vol.99
, pp. 2246-2251
-
-
Solakoglu, O.1
Maierhofer, C.2
Lahr, G.3
Breit, E.4
Scheunemann, P.5
Heumos, I.6
-
58
-
-
0037301144
-
High-resolution genomic profiling of occult micrometastatic tumor cells
-
Kraus J., Pantel K., Pinkel D., Albertson D.G., Speicher M.R. High-resolution genomic profiling of occult micrometastatic tumor cells. Genes Chromosomes Cancer 2003, 36:159-166.
-
(2003)
Genes Chromosomes Cancer
, vol.36
, pp. 159-166
-
-
Kraus, J.1
Pantel, K.2
Pinkel, D.3
Albertson, D.G.4
Speicher, M.R.5
-
59
-
-
2542474181
-
Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients
-
Gangnus R., Langer S., Breit E., Pantel K., Speicher M.R. Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients. Clin. Cancer Res 2004, 10:3457-3464.
-
(2004)
Clin. Cancer Res
, vol.10
, pp. 3457-3464
-
-
Gangnus, R.1
Langer, S.2
Breit, E.3
Pantel, K.4
Speicher, M.R.5
-
60
-
-
84877865227
-
Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing
-
Heitzer E., Auer M., Gasch C., Pichler M., Ulz P., Hoffmann E.M., et al. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res 2013, 73:2965-2975.
-
(2013)
Cancer Res
, vol.73
, pp. 2965-2975
-
-
Heitzer, E.1
Auer, M.2
Gasch, C.3
Pichler, M.4
Ulz, P.5
Hoffmann, E.M.6
-
61
-
-
70349969478
-
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
-
Shah S.P., Morin R.D., Khattra J., Prentice L., Pugh T., Burleigh A., et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009, 461:809-813.
-
(2009)
Nature
, vol.461
, pp. 809-813
-
-
Shah, S.P.1
Morin, R.D.2
Khattra, J.3
Prentice, L.4
Pugh, T.5
Burleigh, A.6
-
62
-
-
79953766940
-
Tumour evolution inferred by single-cell sequencing
-
Navin N., Kendall J., Troge J., Andrews P., Rodgers L., McIndoo J., et al. Tumour evolution inferred by single-cell sequencing. Nature 2011, 472:90-94.
-
(2011)
Nature
, vol.472
, pp. 90-94
-
-
Navin, N.1
Kendall, J.2
Troge, J.3
Andrews, P.4
Rodgers, L.5
McIndoo, J.6
-
63
-
-
84881236533
-
Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratification
-
Schoenborn J.R., Nelson P., Fang M. Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratification. Clin. Cancer Res 2013, 19:4058-4066.
-
(2013)
Clin. Cancer Res
, vol.19
, pp. 4058-4066
-
-
Schoenborn, J.R.1
Nelson, P.2
Fang, M.3
-
64
-
-
84898895483
-
Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis
-
Thege F.I., Lannin T.B., Saha T.N., Tsai S., Kochman M.L., Hollingsworth M.A., et al. Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis. Lab Chip 2014, 14:1775-1784.
-
(2014)
Lab Chip
, vol.14
, pp. 1775-1784
-
-
Thege, F.I.1
Lannin, T.B.2
Saha, T.N.3
Tsai, S.4
Kochman, M.L.5
Hollingsworth, M.A.6
-
65
-
-
84926419351
-
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
-
Pestrin M., Salvianti F., Galardi F., De Luca F., Turner N., Malorni L., et al. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients. Mol. Oncol 2015, 9:749-757.
-
(2015)
Mol. Oncol
, vol.9
, pp. 749-757
-
-
Pestrin, M.1
Salvianti, F.2
Galardi, F.3
De Luca, F.4
Turner, N.5
Malorni, L.6
-
66
-
-
84872048462
-
Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer
-
Gasch C., Bauernhofer T., Pichler M., Langer-Freitag S., Reeh M., Seifert A.M., et al. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer. Clin. Chem 2013, 59:252-260.
-
(2013)
Clin. Chem
, vol.59
, pp. 252-260
-
-
Gasch, C.1
Bauernhofer, T.2
Pichler, M.3
Langer-Freitag, S.4
Reeh, M.5
Seifert, A.M.6
-
67
-
-
84887613659
-
Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution
-
Patel L.R., Nykter M., Chen K., Zhang W. Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution. Cancer Lett 2013, 340:152-160.
-
(2013)
Cancer Lett
, vol.340
, pp. 152-160
-
-
Patel, L.R.1
Nykter, M.2
Chen, K.3
Zhang, W.4
-
68
-
-
33746851956
-
Tumor metastasis: mechanistic insights and clinical challenges
-
Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med 2006, 12:895-904.
-
(2006)
Nat. Med
, vol.12
, pp. 895-904
-
-
Steeg, P.S.1
-
69
-
-
34548238762
-
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab
-
Khambata-Ford S., Garrett C.R., Meropol N.J., Basik M., Harbison C.T., Wu S., et al. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J. Clin. Oncol 2007, 25:3230-3237.
-
(2007)
J. Clin. Oncol
, vol.25
, pp. 3230-3237
-
-
Khambata-Ford, S.1
Garrett, C.R.2
Meropol, N.J.3
Basik, M.4
Harbison, C.T.5
Wu, S.6
-
70
-
-
54949085398
-
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
-
Karapetis C.S., Khambata-Ford S., Jonker D.J., O'Callaghan C.J., Tu D., Tebbutt N.C., et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N. Engl. J. Med 2008, 359:1757-1765.
-
(2008)
N. Engl. J. Med
, vol.359
, pp. 1757-1765
-
-
Karapetis, C.S.1
Khambata-Ford, S.2
Jonker, D.J.3
O'Callaghan, C.J.4
Tu, D.5
Tebbutt, N.C.6
-
71
-
-
84862999938
-
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
-
Misale S., Yaeger R., Hobor S., Scala E., Janakiraman M., Liska D., et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 2012, 486:532-536.
-
(2012)
Nature
, vol.486
, pp. 532-536
-
-
Misale, S.1
Yaeger, R.2
Hobor, S.3
Scala, E.4
Janakiraman, M.5
Liska, D.6
-
72
-
-
79957523828
-
KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
-
De Roock W., De Vriendt V., Normanno N., Ciardiello F., Tejpar S. KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer. Lancet Oncol 2011, 12:594-603.
-
(2011)
Lancet Oncol
, vol.12
, pp. 594-603
-
-
De Roock, W.1
De Vriendt, V.2
Normanno, N.3
Ciardiello, F.4
Tejpar, S.5
-
73
-
-
84899850606
-
Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer
-
Raimondi C., Nicolazzo C., Gradilone A., Giannini G., De Falco E., Chimenti I., et al. Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer. Cancer Biol. Ther 2014, 15:496-503.
-
(2014)
Cancer Biol. Ther
, vol.15
, pp. 496-503
-
-
Raimondi, C.1
Nicolazzo, C.2
Gradilone, A.3
Giannini, G.4
De Falco, E.5
Chimenti, I.6
-
74
-
-
84930616776
-
Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue
-
Lyberopoulou A., Aravantinos G., Efstathopoulos E.P., Nikiteas N., Bouziotis P., Isaakidou A., et al. Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue. PLoS ONE 2015, 10:e0123902.
-
(2015)
PLoS ONE
, vol.10
, pp. e0123902
-
-
Lyberopoulou, A.1
Aravantinos, G.2
Efstathopoulos, E.P.3
Nikiteas, N.4
Bouziotis, P.5
Isaakidou, A.6
-
75
-
-
84876674310
-
KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
-
Mostert B., Jiang Y., Sieuwerts A.M., Wang H., Bolt-de V.J., Biermann K., et al. KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue. Int. J. Cancer 2013, 133:130-141.
-
(2013)
Int. J. Cancer
, vol.133
, pp. 130-141
-
-
Mostert, B.1
Jiang, Y.2
Sieuwerts, A.M.3
Wang, H.4
Bolt-de, V.J.5
Biermann, K.6
-
76
-
-
84926420107
-
Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients
-
Mohamed S.N.A., Foong Y.M., Lee D.Y., Phyo W.M., Cima I., Lee E.X., et al. Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients. Mol. Oncol 2015, 9:850-860.
-
(2015)
Mol. Oncol
, vol.9
, pp. 850-860
-
-
Mohamed, S.N.A.1
Foong, Y.M.2
Lee, D.Y.3
Phyo, W.M.4
Cima, I.5
Lee, E.X.6
-
77
-
-
84878453265
-
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
-
Fabbri F., Carloni S., Zoli W., Ulivi P., Gallerani G., Fici P., et al. Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Lett 2013, 335:225-231.
-
(2013)
Cancer Lett
, vol.335
, pp. 225-231
-
-
Fabbri, F.1
Carloni, S.2
Zoli, W.3
Ulivi, P.4
Gallerani, G.5
Fici, P.6
-
78
-
-
84929939397
-
KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer
-
Kalikaki A., Politaki H., Souglakos J., Apostolaki S., Papadimitraki E., Georgoulia N., et al. KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer. PLoS ONE 2014, 9:e104902.
-
(2014)
PLoS ONE
, vol.9
, pp. e104902
-
-
Kalikaki, A.1
Politaki, H.2
Souglakos, J.3
Apostolaki, S.4
Papadimitraki, E.5
Georgoulia, N.6
-
79
-
-
84886237663
-
Personalized cancer treatment and the myth of KRAS wild-type colon tumors
-
Parsons B.L., Myers M.B. Personalized cancer treatment and the myth of KRAS wild-type colon tumors. Discov. Med 2013, 15:259-267.
-
(2013)
Discov. Med
, vol.15
, pp. 259-267
-
-
Parsons, B.L.1
Myers, M.B.2
-
80
-
-
84906238686
-
Clonal evolution in breast cancer revealed by single nucleus genome sequencing
-
Wang Y., Waters J., Leung M.L., Unruh A., Roh W., Shi X., et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 2014, 512:155-160.
-
(2014)
Nature
, vol.512
, pp. 155-160
-
-
Wang, Y.1
Waters, J.2
Leung, M.L.3
Unruh, A.4
Roh, W.5
Shi, X.6
-
81
-
-
84875211731
-
Cancer heterogeneity: implications for targeted therapeutics
-
Fisher R., Pusztai L., Swanton C. Cancer heterogeneity: implications for targeted therapeutics. Br. J. Cancer 2013, 108:479-485.
-
(2013)
Br. J. Cancer
, vol.108
, pp. 479-485
-
-
Fisher, R.1
Pusztai, L.2
Swanton, C.3
-
82
-
-
84867121875
-
Intratumor heterogeneity: evolution through space and time
-
Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res 2012, 72:4875-4882.
-
(2012)
Cancer Res
, vol.72
, pp. 4875-4882
-
-
Swanton, C.1
-
83
-
-
84884216369
-
Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients
-
Babayan A., Hannemann J., Spotter J., Muller V., Pantel K., Joosse S.A. Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients. PLoS ONE 2013, 8:e75038.
-
(2013)
PLoS ONE
, vol.8
, pp. e75038
-
-
Babayan, A.1
Hannemann, J.2
Spotter, J.3
Muller, V.4
Pantel, K.5
Joosse, S.A.6
-
84
-
-
84872188345
-
Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance
-
Garcia-Becerra R., Santos N., Diaz L., Camacho J. Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance. Int. J. Mol. Sci 2012, 14:108-145.
-
(2012)
Int. J. Mol. Sci
, vol.14
, pp. 108-145
-
-
Garcia-Becerra, R.1
Santos, N.2
Diaz, L.3
Camacho, J.4
-
85
-
-
79551576468
-
Mechanisms of endocrine resistance in breast cancer
-
Osborne C.K., Schiff R. Mechanisms of endocrine resistance in breast cancer. Annu. Rev. Med 2011, 62:233-247.
-
(2011)
Annu. Rev. Med
, vol.62
, pp. 233-247
-
-
Osborne, C.K.1
Schiff, R.2
-
86
-
-
84941314043
-
Hormone receptor status and HER2 expression in primary breast cancer compared with synchronous axillary metastases or recurrent metastatic disease
-
Rossi S., Basso M., Strippoli A., Dadduzio V., Cerchiaro E., Barile R., et al. Hormone receptor status and HER2 expression in primary breast cancer compared with synchronous axillary metastases or recurrent metastatic disease. Clin. Breast Cancer 2015, 15(5):307-312.
-
(2015)
Clin. Breast Cancer
, vol.15
, Issue.5
, pp. 307-312
-
-
Rossi, S.1
Basso, M.2
Strippoli, A.3
Dadduzio, V.4
Cerchiaro, E.5
Barile, R.6
-
87
-
-
77954331064
-
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)
-
Hammond M.E., Hayes D.F., Dowsett M., Allred D.C., Hagerty K.L., Badve S., et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch. Pathol. Lab. Med 2010, 134:e48-e72.
-
(2010)
Arch. Pathol. Lab. Med
, vol.134
, pp. e48-e72
-
-
Hammond, M.E.1
Hayes, D.F.2
Dowsett, M.3
Allred, D.C.4
Hagerty, K.L.5
Badve, S.6
-
88
-
-
79959228670
-
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology
-
Somlo G., Lau S.K., Frankel P., Hsieh H.B., Liu X., Yang L., et al. Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology. Breast Cancer Res. Treat 2011, 128:155-163.
-
(2011)
Breast Cancer Res. Treat
, vol.128
, pp. 155-163
-
-
Somlo, G.1
Lau, S.K.2
Frankel, P.3
Hsieh, H.B.4
Liu, X.5
Yang, L.6
-
89
-
-
67349253810
-
Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies
-
Tewes M., Aktas B., Welt A., Mueller S., Hauch S., Kimmig R., et al. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies. Breast Cancer Res. Treat 2009, 115:581-590.
-
(2009)
Breast Cancer Res. Treat
, vol.115
, pp. 581-590
-
-
Tewes, M.1
Aktas, B.2
Welt, A.3
Mueller, S.4
Hauch, S.5
Kimmig, R.6
-
90
-
-
79960453378
-
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients
-
Aktas B., Muller V., Tewes M., Zeitz J., Kasimir-Bauer S., Loehberg C.R., et al. Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients. Gynecol. Oncol 2011, 122:356-360.
-
(2011)
Gynecol. Oncol
, vol.122
, pp. 356-360
-
-
Aktas, B.1
Muller, V.2
Tewes, M.3
Zeitz, J.4
Kasimir-Bauer, S.5
Loehberg, C.R.6
-
91
-
-
84941954718
-
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer
-
Paoletti C., Muniz M.C., Thomas D.G., Griffith K.A., Kidwell K.M., Tokudome N., et al. Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer. Clin. Cancer Res 2015, 21:2487-2498.
-
(2015)
Clin. Cancer Res
, vol.21
, pp. 2487-2498
-
-
Paoletti, C.1
Muniz, M.C.2
Thomas, D.G.3
Griffith, K.A.4
Kidwell, K.M.5
Tokudome, N.6
-
92
-
-
77449088191
-
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
-
Fehm T., Hoffmann O., Aktas B., Becker S., Solomayer E.F., Wallwiener D., et al. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Breast Cancer Res 2009, 11:R59.
-
(2009)
Breast Cancer Res
, vol.11
, pp. R59
-
-
Fehm, T.1
Hoffmann, O.2
Aktas, B.3
Becker, S.4
Solomayer, E.F.5
Wallwiener, D.6
-
93
-
-
84860992610
-
Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen
-
Bordeaux J.M., Cheng H., Welsh A.W., Haffty B.G., Lannin D.R., Wu X., et al. Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen. PLoS ONE 2012, 7:e36559.
-
(2012)
PLoS ONE
, vol.7
, pp. e36559
-
-
Bordeaux, J.M.1
Cheng, H.2
Welsh, A.W.3
Haffty, B.G.4
Lannin, D.R.5
Wu, X.6
-
94
-
-
84874667197
-
Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer
-
Ligthart S.T., Bidard F.C., Decraene C., Bachelot T., Delaloge S., Brain E., et al. Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer. Ann. Oncol 2013, 24:1231-1238.
-
(2013)
Ann. Oncol
, vol.24
, pp. 1231-1238
-
-
Ligthart, S.T.1
Bidard, F.C.2
Decraene, C.3
Bachelot, T.4
Delaloge, S.5
Brain, E.6
-
95
-
-
0036834995
-
Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer
-
Hayes D.F., Walker T.M., Singh B., Vitetta E.S., Uhr J.W., Gross S., et al. Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Int. J. Oncol 2002, 21:1111-1117.
-
(2002)
Int. J. Oncol
, vol.21
, pp. 1111-1117
-
-
Hayes, D.F.1
Walker, T.M.2
Singh, B.3
Vitetta, E.S.4
Uhr, J.W.5
Gross, S.6
-
96
-
-
70449561613
-
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
-
Pestrin M., Bessi S., Galardi F., Truglia M., Biggeri A., Biagioni C., et al. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients. Breast Cancer Res. Treat 2009, 118:523-530.
-
(2009)
Breast Cancer Res. Treat
, vol.118
, pp. 523-530
-
-
Pestrin, M.1
Bessi, S.2
Galardi, F.3
Truglia, M.4
Biggeri, A.5
Biagioni, C.6
-
97
-
-
84892372275
-
Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer
-
Krishnamurthy S., Bischoff F., Ann M.J., Wong K., Pham T., Kuerer H., et al. Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer. Cancer Med 2013, 2:226-233.
-
(2013)
Cancer Med
, vol.2
, pp. 226-233
-
-
Krishnamurthy, S.1
Bischoff, F.2
Ann, M.J.3
Wong, K.4
Pham, T.5
Kuerer, H.6
-
98
-
-
84902705681
-
Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow
-
Deng G., Krishnakumar S., Powell A.A., Zhang H., Mindrinos M.N., Telli M.L., et al. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow. BMC Cancer 2014, 14:456.
-
(2014)
BMC Cancer
, vol.14
, pp. 456
-
-
Deng, G.1
Krishnakumar, S.2
Powell, A.A.3
Zhang, H.4
Mindrinos, M.N.5
Telli, M.L.6
-
99
-
-
84864408769
-
Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implications
-
Marchetti A., Del G.M., Filice G., Felicioni L., Rossi G., Graziano P., et al. Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implications. PLoS ONE 2012, 7:e42164.
-
(2012)
PLoS ONE
, vol.7
, pp. e42164
-
-
Marchetti, A.1
Del, G.M.2
Filice, G.3
Felicioni, L.4
Rossi, G.5
Graziano, P.6
-
100
-
-
28444455958
-
Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR
-
Bell D.W., Gore I., Okimoto R.A., Godin-Heymann N., Sordella R., Mulloy R., et al. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR. Nat. Genet 2005, 37:1315-1316.
-
(2005)
Nat. Genet
, vol.37
, pp. 1315-1316
-
-
Bell, D.W.1
Gore, I.2
Okimoto, R.A.3
Godin-Heymann, N.4
Sordella, R.5
Mulloy, R.6
-
101
-
-
21144439000
-
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
-
Kwak E.L., Sordella R., Bell D.W., Godin-Heymann N., Okimoto R.A., Brannigan B.W., et al. Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:7665-7670.
-
(2005)
Proc. Natl. Acad. Sci. U.S.A.
, vol.102
, pp. 7665-7670
-
-
Kwak, E.L.1
Sordella, R.2
Bell, D.W.3
Godin-Heymann, N.4
Okimoto, R.A.5
Brannigan, B.W.6
-
102
-
-
47949114668
-
Detection of mutations in EGFR in circulating lung-cancer cells
-
Maheswaran S., Sequist L.V., Nagrath S., Ulkus L., Brannigan B., Collura C.V., et al. Detection of mutations in EGFR in circulating lung-cancer cells. N. Engl. J. Med 2008, 359:366-377.
-
(2008)
N. Engl. J. Med
, vol.359
, pp. 366-377
-
-
Maheswaran, S.1
Sequist, L.V.2
Nagrath, S.3
Ulkus, L.4
Brannigan, B.5
Collura, C.V.6
-
103
-
-
84923014763
-
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment
-
Marchetti A., Del G.M., Felicioni L., Malatesta S., Filice G., Centi I., et al. Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment. PLoS ONE 2014, 9:e103883.
-
(2014)
PLoS ONE
, vol.9
, pp. e103883
-
-
Marchetti, A.1
Del, G.M.2
Felicioni, L.3
Malatesta, S.4
Filice, G.5
Centi, I.6
-
104
-
-
79957916527
-
Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer
-
Wu J.Y., Yu C.J., Chang Y.C., Yang C.H., Shih J.Y., Yang P.C. Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer. Clin. Cancer Res 2011, 17:3812-3821.
-
(2011)
Clin. Cancer Res
, vol.17
, pp. 3812-3821
-
-
Wu, J.Y.1
Yu, C.J.2
Chang, Y.C.3
Yang, C.H.4
Shih, J.Y.5
Yang, P.C.6
-
105
-
-
84872001511
-
Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors
-
Kobayashi S., Canepa H.M., Bailey A.S., Nakayama S., Yamaguchi N., Goldstein M.A., et al. Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors. J. Thorac. Oncol 2013, 8:45-51.
-
(2013)
J. Thorac. Oncol
, vol.8
, pp. 45-51
-
-
Kobayashi, S.1
Canepa, H.M.2
Bailey, A.S.3
Nakayama, S.4
Yamaguchi, N.5
Goldstein, M.A.6
-
106
-
-
84904121066
-
Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
-
Yu M., Bardia A., Aceto N., Bersani F., Madden M.W., Donaldson M.C., et al. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 2014, 345:216-220.
-
(2014)
Science
, vol.345
, pp. 216-220
-
-
Yu, M.1
Bardia, A.2
Aceto, N.3
Bersani, F.4
Madden, M.W.5
Donaldson, M.C.6
-
107
-
-
84922910667
-
Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine
-
Hiley C., de Bruin E.C., McGranahan N., Swanton C. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine. Genome Biol 2014, 15:453.
-
(2014)
Genome Biol
, vol.15
, pp. 453
-
-
Hiley, C.1
de Bruin, E.C.2
McGranahan, N.3
Swanton, C.4
-
108
-
-
84863011443
-
Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer
-
Su K.Y., Chen H.Y., Li K.C., Kuo M.L., Yang J.C., Chan W.K., et al. Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer. J. Clin. Oncol 2012, 30:433-440.
-
(2012)
J. Clin. Oncol
, vol.30
, pp. 433-440
-
-
Su, K.Y.1
Chen, H.Y.2
Li, K.C.3
Kuo, M.L.4
Yang, J.C.5
Chan, W.K.6
-
109
-
-
73649102105
-
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC
-
Turke A.B., Zejnullahu K., Wu Y.L., Song Y., Dias-Santagata D., Lifshits E., et al. Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. Cancer Cell 2010, 17:77-88.
-
(2010)
Cancer Cell
, vol.17
, pp. 77-88
-
-
Turke, A.B.1
Zejnullahu, K.2
Wu, Y.L.3
Song, Y.4
Dias-Santagata, D.5
Lifshits, E.6
-
110
-
-
84943654057
-
High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer
-
Pailler E., Auger N., Lindsay C.R., Vielh P., Islas-Morris-Hernandez A., Borget I., et al. High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer. Ann. Oncol 2015, 26:1408-1415.
-
(2015)
Ann. Oncol
, vol.26
, pp. 1408-1415
-
-
Pailler, E.1
Auger, N.2
Lindsay, C.R.3
Vielh, P.4
Islas-Morris-Hernandez, A.5
Borget, I.6
-
111
-
-
84949944937
-
The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer
-
Middleton G., Crack L.R., Popat S., Swanton C., Hollingsworth S.J., Buller R., et al. The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer. Ann. Oncol 2015, 26:2464-2469.
-
(2015)
Ann. Oncol
, vol.26
, pp. 2464-2469
-
-
Middleton, G.1
Crack, L.R.2
Popat, S.3
Swanton, C.4
Hollingsworth, S.J.5
Buller, R.6
-
112
-
-
84905370049
-
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study
-
Jamal-Hanjani M., Hackshaw A., Ngai Y., Shaw J., Dive C., Quezada S., et al. Tracking genomic cancer evolution for precision medicine: the lung TRACERx study. PLoS Biol 2014, 12:e1001906.
-
(2014)
PLoS Biol
, vol.12
, pp. e1001906
-
-
Jamal-Hanjani, M.1
Hackshaw, A.2
Ngai, Y.3
Shaw, J.4
Dive, C.5
Quezada, S.6
-
113
-
-
84941629659
-
Serial blood-based analysis of AR-V7 in men with advanced prostate cancer
-
Nakazawa M., Lu C., Chen Y., Paller C.J., Carducci M.A., Eisenberger M.A., et al. Serial blood-based analysis of AR-V7 in men with advanced prostate cancer. Ann. Oncol 2015, 26:1859-1865.
-
(2015)
Ann. Oncol
, vol.26
, pp. 1859-1865
-
-
Nakazawa, M.1
Lu, C.2
Chen, Y.3
Paller, C.J.4
Carducci, M.A.5
Eisenberger, M.A.6
-
114
-
-
84936846423
-
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab
-
Musella V., Pietrantonio F., Di B.E., Iacovelli R., Martinetti A., Sottotetti E., et al. Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab. Int. J. Cancer 2015, 137:1467-1474.
-
(2015)
Int. J. Cancer
, vol.137
, pp. 1467-1474
-
-
Musella, V.1
Pietrantonio, F.2
Di, B.E.3
Iacovelli, R.4
Martinetti, A.5
Sottotetti, E.6
-
115
-
-
3042552362
-
HER-2 gene amplification can be acquired as breast cancer progresses
-
Meng S., Tripathy D., Shete S., Ashfaq R., Haley B., Perkins S., et al. HER-2 gene amplification can be acquired as breast cancer progresses. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:9393-9398.
-
(2004)
Proc. Natl. Acad. Sci. U.S.A.
, vol.101
, pp. 9393-9398
-
-
Meng, S.1
Tripathy, D.2
Shete, S.3
Ashfaq, R.4
Haley, B.5
Perkins, S.6
-
116
-
-
84903289929
-
Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500
-
Smerage J.B., Barlow W.E., Hortobagyi G.N., Winer E.P., Leyland-Jones B., Srkalovic G., et al. Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. J. Clin. Oncol 2014, 32:3483-3489.
-
(2014)
J. Clin. Oncol
, vol.32
, pp. 3483-3489
-
-
Smerage, J.B.1
Barlow, W.E.2
Hortobagyi, G.N.3
Winer, E.P.4
Leyland-Jones, B.5
Srkalovic, G.6
-
117
-
-
84898978284
-
Circulating tumor cells in early bladder cancer: insight into micrometastatic disease
-
Raimondi C., Gradilone A., Gazzaniga P. Circulating tumor cells in early bladder cancer: insight into micrometastatic disease. Expert Rev. Mol. Diagn 2014, 14:407-409.
-
(2014)
Expert Rev. Mol. Diagn
, vol.14
, pp. 407-409
-
-
Raimondi, C.1
Gradilone, A.2
Gazzaniga, P.3
-
118
-
-
84925030440
-
Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer
-
Tewes M., Kasimir-Bauer S., Welt A., Schuler M., Kimmig R., Aktas B. Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer. J. Cancer Res. Clin. Oncol 2015, 141:87-92.
-
(2015)
J. Cancer Res. Clin. Oncol
, vol.141
, pp. 87-92
-
-
Tewes, M.1
Kasimir-Bauer, S.2
Welt, A.3
Schuler, M.4
Kimmig, R.5
Aktas, B.6
-
119
-
-
84871461434
-
Genome-wide detection of single-nucleotide and copy-number variations of a single human cell
-
Zong C., Lu S., Chapman A.R., Xie X.S. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 2012, 338:1622-1626.
-
(2012)
Science
, vol.338
, pp. 1622-1626
-
-
Zong, C.1
Lu, S.2
Chapman, A.R.3
Xie, X.S.4
-
120
-
-
84887237209
-
Investigating intratumour heterogeneity by single-cell sequencing
-
Ren S.C., Qu M., Sun Y.H. Investigating intratumour heterogeneity by single-cell sequencing. Asian J. Androl 2013, 15:729-734.
-
(2013)
Asian J. Androl
, vol.15
, pp. 729-734
-
-
Ren, S.C.1
Qu, M.2
Sun, Y.H.3
-
121
-
-
84942872443
-
Systems biology with high-throughput sequencing reveals genetic mechanisms underlying the metabolic syndrome in the Lyon hypertensive rat
-
Wang J., Ma M.C., Mennie A.K., Pettus J.M., Xu Y., Lin L., et al. Systems biology with high-throughput sequencing reveals genetic mechanisms underlying the metabolic syndrome in the Lyon hypertensive rat. Circ. Cardiovasc. Genet 2015, 8:316-326.
-
(2015)
Circ. Cardiovasc. Genet
, vol.8
, pp. 316-326
-
-
Wang, J.1
Ma, M.C.2
Mennie, A.K.3
Pettus, J.M.4
Xu, Y.5
Lin, L.6
-
122
-
-
84930823710
-
Recent advances and current issues in single-cell sequencing of tumors
-
Sun H.J., Chen J., Ni B., Yang X., Wu Y.Z. Recent advances and current issues in single-cell sequencing of tumors. Cancer Lett 2015, 365:1-10.
-
(2015)
Cancer Lett
, vol.365
, pp. 1-10
-
-
Sun, H.J.1
Chen, J.2
Ni, B.3
Yang, X.4
Wu, Y.Z.5
-
123
-
-
84884280606
-
Comparison of select cancer biomarkers in human circulating and bulk tumor cells using magnetic nanoparticles and a miniaturized micro-NMR system
-
Ghazani A.A., McDermott S., Pectasides M., Sebas M., Mino-Kenudson M., Lee H., et al. Comparison of select cancer biomarkers in human circulating and bulk tumor cells using magnetic nanoparticles and a miniaturized micro-NMR system. Nanomedicine 2013, 9:1009-1017.
-
(2013)
Nanomedicine
, vol.9
, pp. 1009-1017
-
-
Ghazani, A.A.1
McDermott, S.2
Pectasides, M.3
Sebas, M.4
Mino-Kenudson, M.5
Lee, H.6
|